Geriatric committee
What we do
The Geriatric Committee aims to encourage the international development of geriatric pharmacology and to advocate for the therapeutic needs of older people.
Our goal is to improve the use of drugs in older people and the development new therapeutic approaches for the syndromes and diseases of old age.
What we do
The Geriatric Committee aims to encourage the international development of geriatric pharmacology and to advocate for the therapeutic needs of older people.
Our goal is to improve the use of drugs in older people and the development new therapeutic approaches for the syndromes and diseases of old age.
Our Activities
- Education: webinars and seminars at relevant conferences to promote geriatric pharmacology; curricula and resources to support education in geriatric pharmacology; mentorship.
- Research: synthesize principles to guide research in geriatric pharmacology covering drug development, evaluation and use; engage with basic research applicable to translational geriatric pharmacology.
- Advocacy: engage with regulatory agencies, governmental offices and relevant organizations to improve safety, efficacy and access to pharmacological treatments for older patients.
Meetings, Events and Highlights
Recordings
As part of World Smart Medication Day 2024, the IUPHAR Geriatric Committee organised a webinar focusing on the similarities and differences between paediatric and geriatric clinical pharmacology. The recordings of the presentations are now available for viewing.
Watch the WSMD 2024 recordings
Publications
-
World Smart Medication Day 2024
From cradle to cane—(Dis)similarities between paediatric and geriatric clinical pharmacology: A commentary arising from the 2024 International Union of Basic and Clinical Pharmacology (IUPHAR) World Smart Medication Day – Allegaert – British Journal of Clinical Pharmacology.
Learn more -
International Geriatric Clinical Pharmacology Curriculum
IUPHAR International geriatric clinical pharmacology curriculum for medical students.
Learn more -
Evaluation of Vaccines for Older Adults
Development, evaluation and use of COVID-19 vaccines in older adults: Preliminary principles for the pandemic and beyond.
Learn more -
Evaluation of New Drugs for Older Adults
Addressing the gaps in evaluation of new drugs for older adults: Strategies from the International Union of Basic and Clinical Pharmacology (IUPHAR) Geriatric Committee.
Learn more
